PT2361081T - Forma de dosagem intra-oral multiporção e seu uso - Google Patents

Forma de dosagem intra-oral multiporção e seu uso

Info

Publication number
PT2361081T
PT2361081T PT98208432T PT09820843T PT2361081T PT 2361081 T PT2361081 T PT 2361081T PT 98208432 T PT98208432 T PT 98208432T PT 09820843 T PT09820843 T PT 09820843T PT 2361081 T PT2361081 T PT 2361081T
Authority
PT
Portugal
Prior art keywords
dosage form
oral dosage
multi portion
portion intra
intra
Prior art date
Application number
PT98208432T
Other languages
English (en)
Inventor
Lindell Katarina
Nicklasson Fredrik
Thyresson Kristina
Bunick Frank
Luber Joe
Hugerth Andreas
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2361081(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of PT2361081T publication Critical patent/PT2361081T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PT98208432T 2008-10-14 2009-10-13 Forma de dosagem intra-oral multiporção e seu uso PT2361081T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0802189 2008-10-14

Publications (1)

Publication Number Publication Date
PT2361081T true PT2361081T (pt) 2016-09-05

Family

ID=42106720

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98208432T PT2361081T (pt) 2008-10-14 2009-10-13 Forma de dosagem intra-oral multiporção e seu uso

Country Status (15)

Country Link
EP (1) EP2361081B1 (pt)
JP (1) JP2012505878A (pt)
KR (1) KR20110071008A (pt)
CN (1) CN102186461A (pt)
AR (1) AR073851A1 (pt)
AU (1) AU2009303979A1 (pt)
BR (1) BRPI0920216A2 (pt)
CA (1) CA2737307A1 (pt)
DK (1) DK2361081T3 (pt)
ES (1) ES2592882T3 (pt)
MX (1) MX2011003984A (pt)
NZ (1) NZ591710A (pt)
PT (1) PT2361081T (pt)
RU (1) RU2011119494A (pt)
WO (1) WO2010044736A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3967298A1 (en) 2020-06-30 2022-03-16 Uniwersytet Rzeszowski Aerosol composition for oral use

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648421B1 (en) 2003-07-24 2017-10-18 GlaxoSmithKline LLC Orally dissolving films
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
AR071420A1 (es) 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
CA2775890C (en) 2009-09-30 2016-06-21 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
US9675102B2 (en) * 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
WO2012048710A1 (en) 2010-10-15 2012-04-19 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
EP2491788B1 (en) 2011-02-25 2015-12-23 Kraft Foods R & D, Inc. Food product with a moulded body
US20130078307A1 (en) * 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
NZ700474A (en) 2012-04-18 2016-10-28 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
PL220354B1 (pl) 2012-11-19 2015-10-30 Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US20150290107A1 (en) 2013-03-14 2015-10-15 3 In 1 Dental Pllc Compositions for treatment of xerostomia and for tooth treatment
WO2014143019A1 (en) * 2013-03-15 2014-09-18 Colgate-Palmolive Company Oral care compositions
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP3427732A1 (en) * 2013-07-31 2019-01-16 Intelgenx Corporation Instantly wettable oral film dosage form without surfactant or polyalcohol
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
ES2842585T3 (es) * 2013-10-03 2021-07-14 Altria Client Services Llc Pastilla para chupar
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3871515A1 (en) 2014-05-27 2021-09-01 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB201411526D0 (en) * 2014-06-27 2014-08-13 British American Tobacco Co Powder
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
KR101506708B1 (ko) 2014-09-03 2015-03-30 주식회사 다림바이오텍 금연 보조용 설하분무제와 트로키를 제조하는 방법 및 이에 의하여 제조된 설하분무제와 트로키
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
US20160198759A1 (en) * 2015-01-13 2016-07-14 Zip Llc E-cigarette or vaping fluid
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CN105343887B (zh) * 2015-10-30 2018-04-27 济南康和医药科技有限公司 一种右佐匹克隆口腔速溶膜及其制备方法
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
JP7137850B2 (ja) 2017-03-03 2022-09-15 シーティーシー バイオ インク バレニクリンまたはその薬学的に許容可能な塩の包接複合体を含む口腔投与用製剤
CN107028901A (zh) * 2017-03-29 2017-08-11 陈永雷 一种药品含片、功能性食品含片、保健食品含片区域分区制备法
AU2018273539B2 (en) * 2017-05-22 2024-03-21 Johnson & Johnson Consumer Inc. Lozenge dosage form
AU2018378648B2 (en) * 2017-12-08 2021-06-03 Fertin Pharma A/S Nicotine tablet
CA3085063A1 (en) 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
CN108250506A (zh) * 2018-02-12 2018-07-06 上海星宇医疗器材有限公司 一种亲水性牙根管充填尖及其制备方法
AU2019301234A1 (en) 2018-07-13 2020-12-24 Mcneil Ab Chewing gum comprising nicotine
US11759419B2 (en) * 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
MX2022008736A (es) 2020-01-15 2022-07-21 Mcneil Ab Producto y proceso de fabricacion de una goma.
CN114929339A (zh) 2020-01-15 2022-08-19 麦克内尔股份公司 产品和制备口香糖的方法
CN111053761B (zh) * 2020-01-16 2022-05-03 杭州旦承医药科技有限公司 一种吸入用双膦酸类药物及其制备方法及其在慢性阻塞性肺疾病的用途
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
CN111419726A (zh) * 2020-04-30 2020-07-17 云南风联科技有限公司 一种植物陈皮烟草香型口腔雾化液及制备方法
CN112220756B (zh) * 2020-10-16 2023-06-13 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法
CN112220757B (zh) * 2020-10-16 2022-05-27 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法及其制备装置
CN113880802A (zh) * 2021-11-09 2022-01-04 深圳萨特瓦生物科技有限公司 酒石酸-尼古丁盐及其制备方法与应用、无水酒石酸晶体的制备方法
US11786473B2 (en) 2021-12-14 2023-10-17 Fertin Pharma A/S Nicotine tablet

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
DK615689A (da) * 1989-11-07 1991-05-08 Anders Dam Rygesupplement eller rygeerstatningsprodukt
SE8904295D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
JP3706204B2 (ja) * 1996-08-09 2005-10-12 花王株式会社 口腔用固形製剤
JPH10236948A (ja) * 1996-08-09 1998-09-08 Kao Corp 口腔用固形製剤
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
EP1107730B1 (en) * 1998-09-03 2008-03-12 Jsr Nti Llc Medicated chewing gum delivery system for nicotine
WO2001037814A1 (en) * 1999-11-23 2001-05-31 Robert Gordon University Bilayered buccal tablets comprising nicotine
US6607752B2 (en) * 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
JP5089840B2 (ja) 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
US20040037879A1 (en) 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US7517681B2 (en) * 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
JP4931596B2 (ja) * 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
JP2006232675A (ja) * 2005-02-22 2006-09-07 Kowa Co 複合型口腔内溶解用固形製剤
US20070269492A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
WO2008097539A2 (en) * 2007-02-05 2008-08-14 Jsrnti, Llc Multi-modal absorption, medicine-delivery lozenge, and use thereof
EP2123275A1 (en) * 2007-03-15 2009-11-25 Toyo Boseki Kabushiki Kaisha Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3967298A1 (en) 2020-06-30 2022-03-16 Uniwersytet Rzeszowski Aerosol composition for oral use

Also Published As

Publication number Publication date
EP2361081A1 (en) 2011-08-31
DK2361081T3 (en) 2016-08-15
JP2012505878A (ja) 2012-03-08
CA2737307A1 (en) 2010-04-22
AU2009303979A1 (en) 2010-04-22
EP2361081B1 (en) 2016-06-29
CN102186461A (zh) 2011-09-14
MX2011003984A (es) 2011-05-10
KR20110071008A (ko) 2011-06-27
WO2010044736A1 (en) 2010-04-22
AR073851A1 (es) 2010-12-09
BRPI0920216A2 (pt) 2019-09-24
EP2361081A4 (en) 2013-08-21
RU2011119494A (ru) 2012-11-27
ES2592882T3 (es) 2016-12-02
NZ591710A (en) 2012-11-30

Similar Documents

Publication Publication Date Title
EP2361081A4 (en) MULTI-PARALLEL INTRA-ORAL DOSAGE FORM AND USE THEREOF
IL271132A (en) New preparation and dosage
IL206288A0 (en) Novel dosage and formulation
GB0803018D0 (en) Therapeutic compounds and their use
ZA201006029B (en) Pharmaceutical dosage form
GB0804685D0 (en) Therapeutic compounds and their use
HK1154484A1 (en) Oral dosage composition
IL205160A0 (en) Oral dosage forms comprising licarbazepine acetate
PL2167033T3 (pl) Podawana raz dziennie doustna postać dawkowania zawierająca takrolimus
HK1151791A1 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
GB0807609D0 (en) Therapeutic compounds and their use
GB0710439D0 (en) Oral dosage form
GB0817207D0 (en) therapeutic apsac compounds and their use
ZA200903858B (en) Pharmaceutical dosage form
GB0817208D0 (en) Therapeutic apsap compounds and their use
ZA201201676B (en) Azetidinone compounds and medical use thereof
HK1160761A1 (en) Medicament dispenser and its use
PT2154144E (pt) Oligonucleotídeos e utilização dos mesmos
GB0822124D0 (en) Oral dosage form
EP2431365A4 (en) AZETIDINE COMPOUND AND ITS MEDICAL USE
GB0812913D0 (en) Therapeutic compounds and their use
EP2231163A4 (en) COMPOUNDS AND THEIR THERAPEUTIC USE
GB0802128D0 (en) Therapeutic compounds and their use
GB0717450D0 (en) Medicament
GB0815134D0 (en) Therapeutic compounds and their use